Long-term Ophthalmic Outcomes in Ex-premature Infants

Sponsor
Erasmus Medical Center
Study ID
NCT06649513
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Premature Birth
  • Retinopathy of Prematurity (ROP)

Eligibility Criteria

Sex
ALL
Age
16 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • eye drops (Tropicamid) — DIAGNOSTIC_TEST
    Mydriatic + cycloplegic eye drops are given to measure refractive error and to image the full retina.

Study Details

There is limited knowledge on ophthalmological outcomes in the adult population that was born prematurely. This study aims to evaluate the ophthalmic outcomes of ex-premature infants that have reached adolescence or adulthood.

Key Dates

First listed
Oct 18, 2024
Start date
Nov 1, 2024
Status verified
Oct 2024
Primary completion
Nov 1, 2029
Completion
Nov 1, 2030

Study Design

Enrollment
210 participants (estimated)

Arms

  • Arm: Preterm patients
    Former patients who were born prematurely (GA \< 37 weeks)

Primary Outcome Measure

Visual acuity [ Time Frame: The primary outcome measure will be assessed at one single visit to Erasmus MC. This one-off measurement will not be repeated, nor is there a specific time-frame for this measurement. ]

Central Contacts

Related Studies